Loading
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (1 ops.)
Latest filing published 20 Jun 2024 for Transphorm, Inc., €116.3M.
Filing timeline
BuySaleKKR Phorm Investors L.P.
Insider track record
Disclosed buys
3
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
KKR Phorm Investors L.P.: trading record in brief
KKR Phorm Investors L.P. is a declared insider of Transphorm, Inc., with filings sourced from SEC (Form 4). We count 5 filings; the first trade dates from 12 February 2020 and the latest from 20 June 2024.
The open-market side counts 3 purchases for €14.0M alongside 1 sale for €116.3M. Netting one side against the other leaves €102.2M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 share grant. 2024 to date brings no purchases and 1 sale.
Half of the purchases are above €4.6M and half below.
The record was last updated on 20 June 2024 with an open-market sale (€116.3M) in Transphorm, Inc. The latest purchase dates back some time: it was published 1,187 days ago, on 25 July 2023. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to KKR Phorm Investors L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
24,411,968 shares@ US$5.1087.8% of flowCommon StockSEC:0001140361-24-030747:0
1,735,988 shares@ US$3.303.9% of flowCommon StockSEC:0001140361-23-036060:0
Canonical exit: 19 Oct 2023 (T+90)
500,000 shares@ US$5.001.8% of flowCommon StockSEC:0001140361-22-021814:0
1,000,000 shares@ US$5.003.4% of flowCommon StockSEC:0001140361-21-036906:0
Canonical exit: 3 Feb 2022 (T+90)
4 of 4 declarations
